share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leiderman Elisabeth

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Leiderman Elisabeth

bluebird bio | 4:持股變動聲明-董事 Leiderman Elisabeth
美股SEC公告 ·  11/09 05:16

Moomoo AI 已提取核心訊息

Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.
Elisabeth Leiderman, associated with bluebird bio, Inc. [BLUE], completed a stock acquisition on November 6, 2024. The transaction involved a grant of 24,900 shares of common stock at no cost. Following the transaction, Leiderman's direct holdings in the company increased to a total of 47,156 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment of its executives to the company's success.
Elisabeth Leiderman,是藍鳥生物公司[BLUE]的相關人士,在2024年11月6日完成了一筆股票收購交易。該交易涉及免費獲得24900股普通股。在該交易之後,Leiderman在該公司的直接持股增至總共47156股。該授予是公司薪酬結構的一部分,反映了公司高管對公司成功的持續承諾。
Elisabeth Leiderman,是藍鳥生物公司[BLUE]的相關人士,在2024年11月6日完成了一筆股票收購交易。該交易涉及免費獲得24900股普通股。在該交易之後,Leiderman在該公司的直接持股增至總共47156股。該授予是公司薪酬結構的一部分,反映了公司高管對公司成功的持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息